Search

Author/Creator Vasudev, Naveen

1. Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial. Issue 5 (May 2022)

Authors:
Hussain, Syed A; Lester, Jason F; Jackson, Richard; Gornall, Matthew; Qureshi, Muneeb; Elliott, Anthony; Crabb, Simon J; Huddart, Robert A; Vasudev, Naveen; Birtle, Alison J; Worlding, Jane; James, Nicholas D; Parikh, Omi; Vilarino-Varela, Maria; Alonzi, Roberto; Linch, Mark D; Riaz, Irbaz B; Cat...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 5(2022)
Page Start:
650
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. Issue 12 (December 2020)

Authors:
Powles, Thomas; van der Heijden, Michiel S; Castellano, Daniel; Galsky, Matthew D; Loriot, Yohann; Petrylak, Daniel P; Ogawa, Osamu; Park, Se Hoon; Lee, Jae-Lyun; De Giorgi, Ugo; Bögemann, Martin; Bamias, Aristotelis; Eigl, Bernhard J; Gurney, Howard; Mukherjee, Som D; Fradet, Yves; Skoneczna, Iw...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 12(2020)
Page Start:
1574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. MP50-04 MULTIMODAL IMAGE-GUIDED ABLATION ON MANAGEMENT OF RENAL CANCER IN VON-HIPPEL-LINDAU (VHL) SYNDROME PATIENTS FROM 2004 TO 2021 AT A SPECIALIST CENTRE: A LONGITUDINAL OBSERVATIONAL STUDY. (May 2022)

Authors:
Wai-Shun Chan, Vinson; Lenton, James; Smith, Jonathan; Jagdev, Satinder; Ralph, Christy; Vasudev, Naveen; Bhattarai, Selina; Lewington, Andrew; Kimuli, Michael; Cartledge, Jon; Wah, Tze Min
Journal:
Journal of urology
Issue:
Volume 207(2022)Supplement 5
Page Start:
e864
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Multimodal image-guided ablation on management of renal cancer in Von-Hippel-Lindau syndrome patients from 2004 to 2021 at a specialist centre: A longitudinal observational study. Issue 3 (March 2022)

Authors:
Chan, Vinson Wai-Shun; Lenton, James; Smith, Jonathan; Jagdev, Satinder; Ralph, Christy; Vasudev, Naveen; Bhattarai, Selina; Lewington, Andrew; Kimuli, Michael; Cartledge, Jon; Wah, Tze Min
Journal:
European journal of surgical oncology
Issue:
Volume 48:Issue 3(2022)
Page Start:
672
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. PD18-08 PROGNOSTIC VALUE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO AND PLATELET-TO-LYMPHOCYTE RATIO FOR SMALL RENAL CELL CARCINOMAS AFTER IMAGE-GUIDED CRYOABLATION (CRYO) OR RADIO-FREQUENCY ABLATION (RFA). (May 2022)

Authors:
Asif, Aqua; Osman, Filzah Hanis; Sze-Ern Koe, Jasmine; Ng, Alexander; Cartledge, Jon; Kimuli, Michael; Vasudev, Naveen; Ralph, Christy; Jagdev, Satinder; Bhattarai, Selina; Smith, Jonathan; Lenton, James; Wai-Shun Chan, Vinson; Wah, Tze Min
Journal:
Journal of urology
Issue:
Volume 207(2022)Supplement 5
Page Start:
e346
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. Issue 3 (March 2023)

Authors:
Brown, Janet E; Royle, Kara-Louise; Gregory, Walter; Ralph, Christy; Maraveyas, Anthony; Din, Omar; Eisen, Timothy; Nathan, Paul; Powles, Tom; Griffiths, Richard; Jones, Robert; Vasudev, Naveen; Wheater, Matthew; Hamid, Abdel; Waddell, Tom; McMenemin, Rhona; Patel, Poulam; Larkin, James; Faust, G...
Journal:
Lancet oncology
Issue:
Volume 24:Issue 3(2023)
Page Start:
213
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗